Management of hereditary hemorrhagic telangiectasia-like symptoms induced by trastuzumab emtansine in a breast cancer patient: case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of hereditary hemorrhagic telangiectasia-like symptoms induced by trastuzumab emtansine in a breast cancer patient: case report

Published:2024-07-19 Issue: Volume: Page:1-5
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Tyburec Micaela¹^ORCID,Braslavsky Ana²³^ORCID,Serrano Candelaria²⁴^ORCID,Vázquez Carolina²³^ORCID,Serra Marcelo²³⁵^ORCID

Affiliation:

1. Instituto Universitario Hospital Italiano, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

2. Argentine Rendu Study Group (ARG), Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

3. Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

4. ENT Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

5. HHT Unit and Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2024.2379169

Reference14 articles.

1. Adverse Events of Trastuzumab Emtansine (T-DM1) in the Treatment of HER2-Positive Breast Cancer Patients

2. Potential Mechanisms for Thrombocytopenia Development with Trastuzumab Emtansine (T-DM1)

3. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia

4. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome)

5. Trastuzumab emtansine: mechanisms of action and drug resistance

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP